Andrén P, Jakubovski E, Murphy TL, Woitecki K, Tarnok Z, Zimmerman-Brenner S, van de Griendt J, Debes NM, Viefhaus P, Robinson S, Roessner V, Ganos C, Szejko N, Müller-Vahl KR, Cath D, Hartmann A, Verdellen C (2022) European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part II: psychological interventions. Eur Child Adolesc Psychiatry 31(3):403–423. https://doi.org/10.1007/s00787-021-01845-z
Bhikram T, Elmaghraby R, Abi-Jaoude E, Sandor P (2021) An international survey of health care services available to patients with Tourette syndrome. Front Psych 12:621874. https://doi.org/10.3389/fpsyt.2021.621874
Bloch MH, Leckman JF (2009) Clinical course of Tourette syndrome. J Psychosom Res 67(6):497–501. https://doi.org/10.1016/j.jpsychores.2009.09.002
Article PubMed PubMed Central Google Scholar
Coffey B, Jankovic J, Claassen DO, Jimenez-Shahed J, Gertz BJ, Garofalo EA, Stamler DA, Wieman M, Savola JM, Gordon MF, Alexander JK, Barkay H, Harary E (2021) Efficacy and safety of fixed-dose deutetrabenazine in children and adolescents for tics associated with Tourette syndrome: a randomized clinical trial. JAMA Netw Open 4(10):e2129397. https://doi.org/10.1001/jamanetworkopen.2021.29397
Article PubMed PubMed Central Google Scholar
Cothros N, Martino D, McMorris C, Stewart D, Tehrani A, Pringsheim T (2019) Prescriptions for alpha agonists and antipsychotics in children and youth with tic disorders: a pharmacoepidemiologic study. Tremor Other Hyperkinet Mov (n Y). https://doi.org/10.7916/tohm.v0.645
Country Reports (2025). Retrieved February 9, 2025, from https://www.countryreports.org/country/Philippines/geography.htm
Cuenca J, Glazebrook C, Kendall T, Hedderly T, Heyman I, Jackson G, Murphy T, Rickards H, Robertson M, Stern J, Trayner P, Hollis C (2015) Perceptions of treatment for tics among young people with Tourette syndrome and their parents: a mixed methods study. BMC Psychiatry 15:46. https://doi.org/10.1186/s12888-015-0430-0
Article PubMed PubMed Central Google Scholar
Escobar AM, Munoz D, Gautreau S, Rossi M, Pringsheim T (2025) Tic disorders care gaps in Spanish-speaking Latin America. Mov Disord Clin Pract. https://doi.org/10.1002/mdc3.70020
Farag M, Stern JS, Simmons H, Robertson MM (2015) Serial pharmacological prescribing practices for tic management in Tourette syndrome. Hum Psychopharmacol 30(6):435–441. https://doi.org/10.1002/hup.2495
Article CAS PubMed Google Scholar
Farber RH, Angelov A, Kim K, Carmack T, Thai-Cuarto D, Roberts E (2021) Clinical development of valbenazine for tics associated with Tourette syndrome. Expert Rev Neurother 21(4):393–404. https://doi.org/10.1080/14737175.2021.1898948
Article CAS PubMed Google Scholar
Fletcher J, Dimitropoulos G, Martino D, Wilcox G, MacMaster F, Arnold P, Pringsheim T (2021) Developing a provincial patient support network for children and families affected by Tourette syndrome and/or obsessive-compulsive disorder: results of a stakeholder consultation. Child Adolesc Psychiatry Ment Health 15(1):29. https://doi.org/10.1186/s13034-021-00383-5
Article PubMed PubMed Central Google Scholar
Ganos C, Sarva H, Kurvits L, Gilbert DL, Hartmann A, Worbe Y et al (2021) Clinical practice patterns in tic disorders among movement disorder society members. Tremor Other Hyperkinet Mov 11:43. https://doi.org/10.5334/tohm.656
Gilbert J, Jankovic J (2014) Pharmacological treatment of Tourette syndrome. J Obsessive-Compulsive Relat Disord 3(4):407–414
Hall CL, Le Novere M, Murphy T, McNally E, Hollis C, Hunter R (2024) Healthcare utilization and costs associated with poor access to diagnosis and treatment for children and young people with tic disorders. BMJ Mental Health 27(1):e301241. https://doi.org/10.1136/bmjment-2024-301241
Article PubMed PubMed Central Google Scholar
Hirschtritt ME, Lee PC, Pauls DL, Dion Y, Grados MA, Illmann C, King RA, Sandor P, McMahon WM, Lyon GJ, Cath DC, Kurlan R, Robertson MM, Osiecki L, Scharf JM, Mathews CA, Tourette Syndrome Association International Consortium for Genetics (2015) Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome. JAMA Psychiat 72(4):325–333. https://doi.org/10.1001/jamapsychiatry.2014.2650
Hollis C, Hall CL, Khan K, Jones R, Marston L, Le Novere M, Hunter R, Andrén P, Bennett SD, Brown BJ, Chamberlain LR, Davies EB, Evans A, Kouzoupi N, McKenzie C, Sanderson C, Heyman I, Kilgariff J, Glazebrook C, Mataix-Cols D, Murphy T (2023) Long-term clinical and cost-effectiveness of a therapist-supported online remote behavioural intervention for tics in children and adolescents: extended 12- and 18-month follow-up of a single-blind randomised controlled trial. J Child Psychol Psychiatry 64(6):941–951. https://doi.org/10.1111/jcpp.13756
Johnson KA, Worbe Y, Foote KD, Butson CR, Gunduz A, Okun MS (2023) Tourette syndrome: clinical features, pathophysiology, and treatment. Lancet Neurol 22:147–158. https://doi.org/10.1016/S1474-4422(22)00303-9
Khan K, Hollis C, Murphy T, Hall CL (2022) Digital and remote behavioral therapies for treating tic disorders: recent advances and next steps. Front Psych 13:928487. https://doi.org/10.3389/fpsyt.2022.928487
Kim S, Kim MS, Kim J, Hong SB (2024) Incidence trend and epidemiology of tic disorders among youths and adults in Korea from 2003 to 2020: a national population-based study. Psychiatry Res 331:115634. https://doi.org/10.1016/j.psychres.2023.115634
Ludlow AK, Brown R, Schulz J (2018) A qualitative exploration of the daily experiences and challenges faced by parents and caregivers of children with Tourette’s syndrome. J Health Psychol 23(14):1790–1799. https://doi.org/10.1177/1359105316669878
Marino C, Khan K, Groom MJ, Hall SS, Anderson S, Mcnally E, Murphy T, Hall CL (2023) Patients’ experience of accessing support for tics from primary care in the UK: an online mixed-methods survey. BMC Health Serv Res 23(1):788. https://doi.org/10.1186/s12913-023-09753-5
Article PubMed PubMed Central Google Scholar
MIMS Pte Ltd. (2022). MIMS drug reference (164th ed.). MIMS Pte Ltd.
Müller-Vahl KR, Szejko N, Verdellen C, Roessner V, Hoekstra PJ, Hartmann A, Cath DC (2022) European clinical guidelines for Tourette syndrome and other tic disorders: summary statement. Eur Child Adolesc Psychiatry 31(3):377–382. https://doi.org/10.1007/s00787-021-01832-4
Murphy TK, Fernandez TV, Coffey BJ, Rahman O, Gavaletz A, Hanks CE, Tillberg CS, Gomez LI, Sukhodolsky DG, Katsovich L, Scahill L (2017) Extended-release guanfacine does not show a large effect on tic severity in children with chronic tic disorders. J Child Adolesc Psychopharmacol 27(9):762–770. https://doi.org/10.1089/cap.2017.0024
Article CAS PubMed Google Scholar
Park JI, Jeon M (2016) The stigma of mental illness in Korea. J Korean Neuropsychiatr Assoc 55(4):299–309. https://doi.org/10.4306/jknpa.2016.55.4.299
Parker A, French B, Groom MJ, Hall CL (2024) Systematic review-understanding the barriers and facilitators experienced by healthcare professionals in providing care for tics: a mixed methods systematic review of clinical knowledge, attitudes, and practices. BMC Med Educ 24(1):1403. https://doi.org/10.1186/s12909-024-06369-z
Article PubMed PubMed Central Google Scholar
Regier DA, Kuhl EA, Kupfer DJ (2013) The DSM-5: classification and criteria changes. World Psychiatry 12(2):92–98. https://doi.org/10.1002/wps.20050
Article PubMed PubMed Central Google Scholar
Rivera-Navarro J, Cubo E, Almazan J (2009) The diagnosis of Tourette’s syndrome: communication and impact. Clin Child Psychol Psychiatry 14:13–23. https://doi.org/10.1177/1359104508100127
Rodin A, Fleetwood-Meade K, Gilmour J, Kasujja R, Murphy T (2021) Why don’t children in Uganda have tics? A mixed-methods study of beliefs, knowledge, and attitudes of health professionals. Child Adolesc Mental Health 26:47–53. https://doi.org/10.1111/camh.12370
Roessner V, Eichele H, Stern JS, Skov L, Rizzo R, Debes NM, Nagy P, Cavanna AE, Termine C, Ganos C, Münchau A, Szejko N, Cath D, Müller-Vahl KR, Verdellen C, Hartmann A, Rothenberger A, Hoekstra PJ, Plessen KJ (2022) European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part III: pharmacological treatment. Eur Child Adolesc Psychiatry 31(3):425–441. https://doi.org/10.1007/s00787-021-01899-z
Szejko N, Worbe Y, Hartmann A, Visser-Vandewalle V, Ackermans L, Ganos C, Porta M, Leentjens AFG, Mehrkens JH, Huys D, Baldermann JC, Kuhn J, Karachi C, Delorme C, Foltynie T, Cavanna AE, Cath D, Müller-Vahl K (2022) European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part IV: deep brain stimulation. Eur Child Adolesc Psychiatry 31(3):443–461. https://doi.org/10.1007/s00787-021-01881-9
Comments (0)